Literature DB >> 23676850

The hen as a model of ovarian cancer.

Patricia A Johnson1, James R Giles.   

Abstract

The domestic laying hen is the only non-human animal that spontaneously develops ovarian cancer with a high prevalence. Hens ovulate prolifically, and this has made the hen intuitively appealing as a model of this disease in light of epidemiological evidence that ovulation rate is highly correlated with the risk of human ovarian cancer. As in women, ovarian cancer in the hen is age-related and it is also grossly and histologically similar to that in humans. In both women and hens, the cancer metastasizes to similar tissues with an accumulation of ascites fluid. Some aggressive ovarian cancers in women arise from cells in the oviduct; this is intriguing because ovarian cancers in the hen express an oviductal protein that is normally absent in the ovary.

Entities:  

Mesh:

Year:  2013        PMID: 23676850     DOI: 10.1038/nrc3535

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  52 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Protein synthesis: differential stimulation of cell-specific proteins in epithelial cells of chick oviduct.

Authors:  P O Kohler; P M Grimley; B W O'Malley
Journal:  Science       Date:  1968-04-05       Impact factor: 47.728

3.  Oral contraceptives decrease the prevalence of ovarian cancer in the hen.

Authors:  Lindsey S Treviño; Elizabeth L Buckles; Patricia A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

Review 4.  Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

Authors:  W Glenn McCluggage
Journal:  Pathology       Date:  2011-08       Impact factor: 5.306

5.  Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma.

Authors:  James R Giles; H L Shivaprasad; Patricia A Johnson
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

6.  Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.

Authors:  Katherine V Clark-Knowles; Kenneth Garson; Jos Jonkers; Barbara C Vanderhyden
Journal:  Exp Cell Res       Date:  2006-10-03       Impact factor: 3.905

7.  VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer.

Authors:  M E Urick; J R Giles; P A Johnson
Journal:  Gynecol Oncol       Date:  2008-07-07       Impact factor: 5.482

8.  Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

Authors:  Rong Wu; Neali Hendrix-Lucas; Rork Kuick; Yali Zhai; Donald R Schwartz; Aytekin Akyol; Samir Hanash; David E Misek; Hidetaka Katabuchi; Bart O Williams; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

9.  A study on the origin of adenocarcinoma in fowls using immunohistological technique.

Authors:  M Haritani; H Kajigaya; T Akashi; M Kamemura; N Tanahara; M Umeda; M Sugiyama; M Isoda; C Kato
Journal:  Avian Dis       Date:  1984 Oct-Dec       Impact factor: 1.577

10.  Ovarian tumors of the hen.

Authors:  T N Fredrickson
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

View more
  40 in total

Review 1.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

Review 2.  Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.

Authors:  Anthony N Karnezis; Kathleen R Cho
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

3.  Quantitative mass spectrometry imaging of glutathione in healthy and cancerous hen ovarian tissue sections by infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI).

Authors:  Milad Nazari; Mark T Bokhart; Philip L Loziuk; David C Muddiman
Journal:  Analyst       Date:  2018-01-11       Impact factor: 4.616

4.  Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model.

Authors:  Subbulakshmi Karthikeyan; Angela Russo; Matthew Dean; Daniel D Lantvit; Michael Endsley; Joanna E Burdette
Journal:  Cancer Lett       Date:  2018-07-05       Impact factor: 8.679

Review 5.  The chicken model of spontaneous ovarian cancer.

Authors:  Adam M Hawkridge
Journal:  Proteomics Clin Appl       Date:  2014-10       Impact factor: 3.494

6.  Enhanced Lipidome Coverage in Shotgun Analyses by using Gas-Phase Fractionation.

Authors:  Milad Nazari; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-25       Impact factor: 3.109

7.  In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans.

Authors:  Angelito I Nepomuceno; Huanjie Shao; Kai Jing; Yibao Ma; James N Petitte; Michael O Idowu; David C Muddiman; Xianjun Fang; Adam M Hawkridge
Journal:  Anal Bioanal Chem       Date:  2015-07-10       Impact factor: 4.142

8.  Polarity switching mass spectrometry imaging of healthy and cancerous hen ovarian tissue sections by infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI).

Authors:  Milad Nazari; David C Muddiman
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

9.  Influence of C-Trap Ion Accumulation Time on the Detectability of Analytes in IR-MALDESI MSI.

Authors:  Elias P Rosen; Mark T Bokhart; Milad Nazari; David C Muddiman
Journal:  Anal Chem       Date:  2015-10-06       Impact factor: 6.986

10.  Advantages of the avian model for human ovarian cancer.

Authors:  Ana DE Melo Bernardo; Sólveig Thorsteinsdóttir; Christine L Mummery
Journal:  Mol Clin Oncol       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.